![]() |
|
|
Vol. 287, Issue 3, 868-876, December 1998
Department of Pharmacology, Medical University of South Carolina,
Charleston, South Carolina
Dapsone hydroxylamine (DDS-NOH) is a direct-acting hemolytic
agent responsible for dapsone-induced hemolytic anemia in the rat. The
hemolytic activity of DDS-NOH is associated with the formation of
disulfide-linked hemoglobin adducts on membrane skeletal proteins. We
have postulated that this membrane protein "damage" is a
consequence of DDS-NOH-induced oxidative stress within the red cell and
that it serves as the trigger for premature removal of injured but
intact red cells from the circulation by splenic macrophages. Oxidative
stress has also been associated with the induction of lipid
peroxidation, and it is possible that direct damage to the lipoidal
membrane may play a role in the premature sequestration of the damaged
cells in the spleen. To investigate this possibility, rat and human red
cells were incubated with hemolytic concentrations of DDS-NOH and
examined for evidence of lipid peroxidation using two independent
assays: thiobarbituric acid-reactive substances formation and
cis-paranaric acid degradation. Phenylhydrazine, which is
known to induce lipid peroxidation in red cells, was used as a positive
control. The extent of thiobarbituric acid-reactive substances
formation and cis-paranaric acid degradation in
DDS-NOH-treated rat and human red cells was not significantly different
from that in control cells. In contrast, thiobarbituric acid-reactive
substances formation and cis-paranaric acid degradation were
significantly increased in red cells treated with hemolytic concentrations of the positive control, phenylhydrazine. These data
suggest that lipid peroxidation is not involved in the mechanism underlying dapsone-induced hemolytic anemia.
This article has been cited by other articles:
![]() |
D. C. McMillan, C. L. Powell, Z. S. Bowman, J. D. Morrow, and D. J. Jollow Lipids versus Proteins as Major Targets of Pro-Oxidant, Direct-Acting Hemolytic Agents Toxicol. Sci., November 1, 2005; 88(1): 274 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. C. Bolchoz, J. D. Morrow, D. J. Jollow, and D. C. McMillan Primaquine-Induced Hemolytic Anemia: Effect of 6-Methoxy-8-hydroxylaminoquinoline on Rat Erythrocyte Sulfhydryl Status, Membrane Lipids, Cytoskeletal Proteins, and Morphology J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 141 - 148. [Abstract] [Full Text] [PDF] |
||||